Jacob LaStant

472 total citations
4 papers, 236 citations indexed

About

Jacob LaStant is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Jacob LaStant has authored 4 papers receiving a total of 236 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Genetics and 1 paper in Hematology. Recurrent topics in Jacob LaStant's work include Fibroblast Growth Factor Research (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Epigenetics and DNA Methylation (2 papers). Jacob LaStant is often cited by papers focused on Fibroblast Growth Factor Research (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Epigenetics and DNA Methylation (2 papers). Jacob LaStant collaborates with scholars based in United States, Switzerland and Netherlands. Jacob LaStant's co-authors include J. Michael Bradshaw, Timothy D. Owens, Ken A. Brameld, David Goldstein, Jin Shu, Claire L. Langrish, Dane E. Karr, Mary E. Gerritsen, Jens Oliver Funk and Vernon T. Phan and has published in prestigious journals such as The Journal of Immunology, Journal of Medicinal Chemistry and EMBO Reports.

In The Last Decade

Jacob LaStant

4 papers receiving 229 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jacob LaStant United States	4	144	51	50	48	42	4	236
Jin Shu China	9	111 0.8×	89 1.7×	64 1.3×	52 1.1×	86 2.0×	18	285
Jennifer Postelnek United States	7	86 0.6×	79 1.5×	48 1.0×	119 2.5×	39 0.9×	12	269
Alessandro Bressan Italy	9	151 1.0×	59 1.2×	25 0.5×	61 1.3×	6 0.1×	25	267
Manjola Balliu Italy	10	143 1.0×	128 2.5×	103 2.1×	27 0.6×	11 0.3×	15	232
Charles Sawyers United States	5	148 1.0×	53 1.0×	93 1.9×	11 0.2×	20 0.5×	7	253
Oshrat Hershkovitz‐Rokah Israel	9	233 1.6×	98 1.9×	100 2.0×	41 0.9×	83 2.0×	25	396
Anna Orlova Austria	7	95 0.7×	30 0.6×	18 0.4×	57 1.2×	47 1.1×	15	224
Luana Bavaro Italy	6	101 0.7×	137 2.7×	191 3.8×	13 0.3×	24 0.6×	7	274
Samantha L. Savage United States	5	232 1.6×	46 0.9×	115 2.3×	26 0.5×	9 0.2×	12	314
Marie Laure Bonnet France	8	139 1.0×	115 2.3×	196 3.9×	40 0.8×	18 0.4×	20	327

Countries citing papers authored by Jacob LaStant

Since Specialization

Citations

This map shows the geographic impact of Jacob LaStant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob LaStant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob LaStant more than expected).

Fields of papers citing papers by Jacob LaStant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob LaStant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob LaStant. The network helps show where Jacob LaStant may publish in the future.

Co-authorship network of co-authors of Jacob LaStant

This figure shows the co-authorship network connecting the top 25 collaborators of Jacob LaStant. A scholar is included among the top collaborators of Jacob LaStant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacob LaStant. Jacob LaStant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Langrish, Claire L., J. Michael Bradshaw, Michelle Francesco, et al.. (2021). Preclinical Efficacy and Anti-Inflammatory Mechanisms of Action of the Bruton Tyrosine Kinase Inhibitor Rilzabrutinib for Immune-Mediated Disease. The Journal of Immunology. 206(7). 1454–1468. 68 indexed citations

2.

Basler, Michael, Michelle Lindström, Jacob LaStant, et al.. (2018). Co‐inhibition of immunoproteasome subunits LMP2 and LMP7 is required to block autoimmunity. EMBO Reports. 19(12). 62 indexed citations

3.

Venetsanakos, Eleni, Ken A. Brameld, Vernon T. Phan, et al.. (2017). The Irreversible Covalent Fibroblast Growth Factor Receptor Inhibitor PRN1371 Exhibits Sustained Inhibition of FGFR after Drug Clearance. Molecular Cancer Therapeutics. 16(12). 2668–2676. 22 indexed citations

4.

Brameld, Ken A., Timothy D. Owens, Erik Verner, et al.. (2017). Discovery of the Irreversible Covalent FGFR Inhibitor 8-(3-(4-Acryloylpiperazin-1-yl)propyl)-6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one (PRN1371) for the Treatment of Solid Tumors. Journal of Medicinal Chemistry. 60(15). 6516–6527. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact